Toward Tailored Chemo

Mapping drug responses and tumor genetics could lead to biomarkers for chemotherapy efficacy

A group at UCSF is bringing precision medicine to chemotherapies, with a predictive model for drug responses based on single gene deletions.

Despite advances in immuno-oncology and targeted therapies, nearly 95% of cancer patients receive chemotherapy as “the backbone of their cancer care,” according to Sourav Bandyopadhyay, an assistant professor of bioengineering and therapeutic

Read the full 535 word article

How to gain access

Continue reading with a
two-week free trial.